Stay updated on Venetoclax/Azacitidine Maintenance in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page.

Latest updates to the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies site revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check26 days agoChange DetectedAn NIH notice announces a transition in terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.SummaryDifference0.3%

- Check33 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check40 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check61 days agoChange DetectedA new revision label 'Revision: v3.7.0' was added to the record history, signaling a platform update. The prior 'Revision: v3.6.6' entry was removed from the history.SummaryDifference0.0%

- Check75 days agoChange DetectedThe history now shows a new revision entry updating the page from v3.6.5 to v3.6.6. This represents a small platform update to the record history page.SummaryDifference0.0%

Stay in the know with updates to Venetoclax/Azacitidine Maintenance in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page.